Weight loss drug maker plots ‘buy now, pay later’ offer
Novo Nordisk aims to treat more people who currently cannot access its Wegovy jabs
Novo Nordisk aims to treat more people who currently cannot access its Wegovy jabs
As groundbreaking cancer drug anastrozole becomes available, we explain the 'repurposing’ of medications - and the new ones coming soon
As groundbreaking cancer drug anastrozole becomes available, we explain the 'repurposing’ of medications - and the new ones coming soon
Health service is willing to pay half as much on new drugs to give you ‘perfect health’
Science is moving so quickly that we aren’t taking the time to consider what this holy grail could actually be doing
Questor share tip: While it's not out of the legal woods yet, several cases have been dismissed and momentum is building day-to-day
Questor share tip: The Swiss pharmaceutical company appears to offer the same potential that Eli Lilly did before its 987pc gain
Our high streets are littered with proof that running a chain from thousands of miles away doesn’t work
Pharmaceutical giant agrees to pay claimants but does not admit any wrongdoing
There had been high hopes for a new product which aims to replace the one-time-use adrenaline shots with an easy to use nasal spray
Pharmacists are highly qualified and could be the quick-fix solution you need for your ailment. Here’s what they can do
Start-up raises £80m from investors amid plans to use generative AI to invent new drugs
Questor share tip: If Smith & Nephew can't follow through on its plan to cut costs and increase margins the shares are dead money at best
A sudden rush of demand for Wegovy has been met with mixed reactions in Denmark
Negotiators reject UK demands for patents to protect pharmaceutical giants
Packaging from a highly toxic batch suggested it was British-manufactured, but the UK health regulator said no such company exists
Could a rethink of our drugs regulatory process slow the inevitable conclusion of motor neurone disease?
The WHO says a remedy sold under the brand name Naturcold had more than 200 times the acceptable amount of the solvent diethylene glycol
King’s Fund study finds UK is worst at saving stroke victims while ‘underperforming significantly’ on cancer and life expectancy
Officials launch inquiry into an allegation that a state drug controller was paid £480,000
The latest incident raises further questions about the sector’s credibility and the effectiveness of its regulatory systems
Industry leader says policy shake up is needed to incentivise big pharma to build factories
Cilta-cel, which is not available in UK because of a row with NICE, has been shown to stop spread of incurable condition